JOHNS HOPKINS UNIVERSITY

Their core work

Johns Hopkins University is a top-tier US research university that participates in EU Horizon 2020 primarily as a third-party host institution for European researcher mobility programs (MSCA-RISE staff exchanges and individual fellowships). Their contribution spans an exceptionally wide range of disciplines — from gravitational wave physics and computational toxicology to Latin American history and speech processing — reflecting the university's massive research breadth across medicine, engineering, natural sciences, and humanities. In health-focused projects, they contribute substantive expertise in toxicology modeling, autism research, and patient-reported outcomes standards.

What they specialise in

How they've shifted over time

In the early period (2015–2018), JHU's H2020 involvement centered on applied physics and engineering — fluid dynamics, nanofabrication, micro-robotics, and computational toxicology. From 2019 onward, their portfolio shifted markedly toward fundamental physics (black holes, gravitational waves), biomedical research (autism gut-brain connections, AI-driven toxicology), and surprisingly, humanities and social sciences (Latin American history, empire studies, speech processing). This broadening reflects JHU's role as a general-purpose research destination for European mobility programs rather than a narrowing of strategic focus.

JHU is increasingly hosting European researchers in fundamental science and interdisciplinary humanities, suggesting it remains a prestige destination for MSCA mobility rather than pursuing targeted EU research strategy.

How they like to work

JHU overwhelmingly participates as a third-party partner (23 of 28 projects), meaning they host visiting researchers through MSCA staff exchanges rather than driving project design or execution. They have never coordinated an H2020 project and receive funding directly in only 4-5 projects. With 334 unique partners across 50 countries, they function as a global hub that many European consortia connect to — but the relationship is typically one of access to JHU facilities and expertise rather than deep co-development.

With 334 unique consortium partners across 50 countries, JHU has one of the broadest networks in H2020 — a natural consequence of being a sought-after third-party host for MSCA mobility programs. Their connections span virtually all of Europe plus global partners, though the relationships tend to be project-specific rather than recurring.

What sets them apart

As a world-renowned US research university, JHU offers European consortia access to top-tier American labs, faculty, and infrastructure — particularly valuable for MSCA mobility programs seeking international secondment hosts. Their sheer disciplinary breadth (from gravitational wave detectors to Latin American history to computational toxicology) means they can credibly host researchers in nearly any field. For health-related projects, the Johns Hopkins Medicine brand carries significant weight in clinical research credibility.

Highlights from their portfolio

• ONTOX
  Largest single EC contribution (EUR 985,215) — one of the few projects where JHU is a direct participant working on AI-driven toxicity prediction as an alternative to animal testing.
• GEMMA
  EUR 747,212 in funding for multi-omics autism research linking gut microbiome to neurodevelopment — represents JHU's strongest engagement in translational health research.
• NEWS
  Six-year trilateral EU-US-Japan collaboration in gravitational wave astronomy, reflecting JHU's role in flagship international physics initiatives.